GNS Healthcare Appoints AJPB Editor Jan Berger, MD, to Board
GNS Healthcare, a leading provider of big data analytics in health care, today announced the appointment of Jan Berger, MD, MJ, to its board of directors. Berger, who served CVS Caremark as chief clinical officer for nearly 10 years, is an internationally recognized expert in medication adherence and value-based health care. She is currently president and CEO of Health Intelligence Partners, a consultancy providing business strategies and solutions to clients across the care continuum.
NanoString Announces New PanCancer Immune Panel
The panel, developed in collaboration with immunooncology scientists around the world, including at INSERM, will help researchers create a profile of the human immune response in all cancer types.
Addressing Health Technology Barriers for Baby Boomers
Although baby boomers are expected to place a large burden on healthcare resources, consumer health technologies could help stem increasing needs and costs, according to a new study in the Journal of Medical Internet Research
ONC Revises 2014 EHR Certification
The Office of the National Coordinator for Health IT released a final rule for electronic health record certification that offers more flexibility for health information technology developers, providers, and consumers.
Watchful Waiting in Prostate Cancer: Role of Ethnicity
The retrospective study, conducted at the Thomas Jefferson University in Philadelphia, found that watchful waiting among black men with early stage prostate cancer who had undergone surgery, resulted in a more aggressive disease.
DEA Moves to Curtail Drug Abuse
With the objective of reducing drug abuse, especially by teenagers, the D.E.A. will now allow patients and their relatives to mail-in their unneeded stockpiles of prescription drugs back to the pharmacies.
Superbugs an Increasing Problem in Hospitals
For patients who develop infections while staying in a hospital, the chances of it becoming drug resistant increases 1% for each day of hospitalization, according to researchers from the Medical University of South Carolina (MUSC).
Bristol-Myers Sues Merck Over US Immunotherapy Patent
“Merck is threatening to exploit that invention,” known as immunotherapy, with a later-developed method of treatment, in violation of a May 20 patent, Bristol-Myers said in a lawsuit filed yesterday in federal court in Wilmington, Delaware. The New York-based company is seeking unspecified damages.
Highmark Takes on Outpatient Markups
Highmark, an insurer with its own health system, is challenging a growing and controversial billing practice that also happens to be a central part of some health system integration strategies.